Fennec Pharmaceuticals (FRX.TO) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.3
-0.21
-0.12
-0.03

Details

Expected EPS
-0.12283974904327079
Actual EPS
-0.05412332138552879
Surprise EPS
0.07
Surprise Percent
+55.94%

Description

Fennec Pharmaceuticals (FRX.TO) has reported earnings of -0.05412332138552879 per share for Q2 2025.

0 Comments

Share your thoughts